A separate study from the University of Colorado Anschutz Medical Campus, also using VA data from 21,790 veterans, compared the cardiovascular and kidney safety profiles of three different GLP-1 drugs: liraglutide, semaglutide and dulaglutide
Bottom Line: Ozempics launch in India is more than a product rollout it reflects how diabetes and metabolic health management is rapidly transforming, with implications for patients, clinicians, pharma strategy, and broader healthcare ecosystems
Patients who reach 2.4 mg with manageable side effects are positioned for the longest part of the weight loss curve, which spans the next several months at the maintenance dose
We screen health conditions like high blood pressure early, crafting medical weight management plans that address them safely toward healthy weight
Certain lifestyle changes, like high-protein diets, fiber-rich foods, and regular exercise, can naturally boost satiety hormones, though not as powerfully as medical GLP1 therapy